A detailed history of Anchor Investment Management, LLC transactions in Organon & Co. stock. As of the latest transaction made, Anchor Investment Management, LLC holds 638 shares of OGN stock, worth $9,538. This represents 0.0% of its overall portfolio holdings.

Number of Shares
638
Previous 1,135 43.79%
Holding current value
$9,538
Previous $23.5 Million 48.05%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 21, 2024

SELL
$18.65 - $23.03 $9,269 - $11,445
-497 Reduced 43.79%
638 $12.2 Million
Q2 2024

Sep 20, 2024

SELL
$17.45 - $21.96 $139 - $175
-8 Reduced 0.7%
1,135 $23.5 Million
Q1 2024

May 15, 2024

SELL
$13.78 - $18.8 $151 - $206
-11 Reduced 0.95%
1,143 $21.5 Million
Q4 2023

Jan 02, 2024

BUY
$10.95 - $17.32 $12,636 - $19,987
1,154 New
1,154 $16.6 Million
Q3 2023

Jan 02, 2024

SELL
$16.59 - $23.77 $3,782 - $5,419
-228 Reduced 11.6%
1,738 $30.2 Million
Q2 2023

Jan 02, 2024

BUY
$19.27 - $24.63 $2,601 - $3,325
135 Added 7.37%
1,966 $40.9 Million
Q1 2023

Jan 02, 2024

SELL
$21.42 - $32.08 $942 - $1,411
-44 Reduced 2.35%
1,831 $43.1 Million
Q4 2022

Jan 02, 2024

BUY
$23.31 - $28.61 $16,806 - $20,627
721 Added 62.48%
1,875 $52.4 Million
Q3 2022

Jan 02, 2024

BUY
$23.4 - $34.25 $13,735 - $20,104
587 Added 50.87%
1,741 $40.7 Million
Q2 2022

Jan 02, 2024

SELL
$31.66 - $38.9 $8,136 - $9,997
-257 Reduced 9.85%
2,352 $79.4 Million
Q1 2022

Jan 02, 2024

SELL
$30.45 - $39.36 $19,762 - $25,544
-649 Reduced 19.92%
2,609 $91.1 Million
Q4 2021

Jan 02, 2024

SELL
$28.67 - $37.13 $27,121 - $35,124
-946 Reduced 22.5%
3,258 $99.2 Million
Q3 2021

Jan 02, 2024

BUY
$28.63 - $35.64 $87,321 - $108,702
3,050 Added 264.3%
4,204 $138 Million
Q2 2021

Jan 02, 2024

BUY
$28.45 - $38.0 $122,505 - $163,628
4,306 Added 373.14%
5,460 $165 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.8B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Anchor Investment Management, LLC Portfolio

Follow Anchor Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anchor Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Anchor Investment Management, LLC with notifications on news.